| 【Company Research】Meidong Auto (1268 HK) - Expect profit growth in FY26-27 following 2H25 new-car GPM recovery, new HIMA stores |
| CMBI Fixed Income - FUTLAN/FTLNHDs: An outperformer in a challenging operating environment |
| 【Company Research】3SBio (1530 HK) - Short-term pressure on product sales; ASCO 2026 in focus |
| 【Company Research】Yongda Automobiles (3669 HK) - Recover gradually |
| 【Company Research】Sunny Optical (2382 HK) - 2026 guidance better-than-feared; high-end SP/auto/IoT to drive earnings growth |
| 【Company Research】Pharmaron Beijing (300759 CH) - Landmark CDMO deal to fuel future growth |
| 【Company Research】Innolight (300308 CH) - Stronger into 2026 on 1.6T ramp and SiPh mix |
| 【Company Research】OmniVision (603501 CH) - Higher-value CIS mix expansion supports margin resilience |
| 【Company Research】InnoScience (2577 HK) - GaN-ning momentum one step at a time |
| 【Company Research】Angelalign (6699 HK) - Earnings beat with strong overseas momentum |
公司地址：香港中環花園道三號冠君大廈45-46樓
電話：（852） 3900-0888 傳真：（852） 3761-8788
招銀國際版權所有 Copyright © 2019-2026 CMB International Capital Corporation Limited. All rights reserved.
